Idarucizumab
- Generic Name
- Idarucizumab
- Brand Names
- Praxbind
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1362509-93-0
- Unique Ingredient Identifier
- 97RWB5S1U6
- Background
Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an immunoglobulin G1 isotype molecule that binds to and inactivates the oral anticoagulant dabigatran, thereby reversing its anticoagulant effect. As a direct acting oral anticoagulant (DOAC), one of the risks associated with the use of dabigatran includes bleeding, espeically when g...
- Indication
For use in patients treated with Dabigatran when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.
- Associated Conditions
- Anticoagulant effects of dabigatran
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath